A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2002
11/14/2002	CA2452245A1 Recombinant fusion proteins and the trimers thereof
11/14/2002	CA2447360A1 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio.
11/14/2002	CA2446788A1 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	CA2446735A1 Substituted cyclohexane-1,4-diamine derivatives with an anti-diarrhoea and peripheral analgesic action
11/14/2002	CA2446437A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	CA2446396A1 N-aroyl cyclic amines
11/14/2002	CA2446087A1 Recombinant tumor specific antibody and use thereof
11/14/2002	CA2442969A1 Methods for selective immunomodulation using pimecrolimus
11/14/2002	CA2438978A1 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002	CA2435142A1 Kinases and phosphatases
11/13/2002	EP1256582A1 1h-imidazopyridine derivatives
11/13/2002	EP1256578A1 Thiazole derivatives and their use as cdk inhibitors
11/13/2002	EP1256354A1 Methods for treating cancer
11/13/2002	EP1256353A1 Remedies for sjoegren's syndrome
11/13/2002	EP1256351A1 Novel immune enhancing compositions
11/13/2002	EP1256346A1 Remedies for external use for allergic skin diseases
11/13/2002	EP1255862A2 Method for the positioning of macromolecules and particles
11/13/2002	EP1255844A1 Humanized anti-ccr2 antibodies and methods of use therefor
11/13/2002	EP1255837A2 Il-17 like molecules and uses thereof
11/13/2002	EP1255835A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255834A2 Gtpase activating proteins
11/13/2002	EP1255819A2 Human kinases
11/13/2002	EP1255756A1 Saccharin derivatives as orally active elastase inhibitors
11/13/2002	EP1255752A2 Pyrrole substituted 2-indolinone protein kinase inhibitors
11/13/2002	EP1255751A2 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors
11/13/2002	EP1255749A1 Tyrosine derivatives with anti-leukotriene activity
11/13/2002	EP1255748A1 Beta-alanine derivatives and their use as receptor antagonists
11/13/2002	EP1255738A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
11/13/2002	EP1255732A1 Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives
11/13/2002	EP1255724A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds
11/13/2002	EP1255564A2 Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator
11/13/2002	EP1255563A1 Composition of antigen and glycolipid adjuvant sublingual administration
11/13/2002	EP1255562A2 Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens
11/13/2002	EP1255560A2 Cd40 ligand adjuvant for respiratory syncytial virus vaccine
11/13/2002	EP1255558A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules
11/13/2002	EP1255536A2 Indolinone derivatives for modulation of c-kit tyrosine protein kinase
11/13/2002	EP1255456A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall
11/13/2002	EP1113811B1 Chemokine receptor antagonist and cyclosporin in combined therapy
11/13/2002	EP1084146B1 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
11/13/2002	EP1056451B1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
11/13/2002	EP1003536B1 Immunostimulatory and metastasis inhibiting fermented material from wheat germ
11/13/2002	EP0843557B1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
11/13/2002	EP0738281B1 Peptides and their uses against psoriasis
11/13/2002	EP0650489B1 Rapamycin derivatives
11/13/2002	CN1379816A Human G-protein coupled receptor
11/13/2002	CN1379815A BAFF receptor (BCMA), immunoregulatory agent
11/13/2002	CN1379786A Modified peptides and peptidomimetics for use in immunotherapy
11/13/2002	CN1379777A Amino-triazolopyridine derivatives
11/13/2002	CN1379772A Substituted indoles for modulating NFKB activity
11/13/2002	CN1379763A Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions
11/13/2002	CN1379756A Substituted nor bornylamino derivatives, method for production thereof, use thereof as medicament or diagnostic reagent medicaments containing said compounds
11/13/2002	CN1379755A Substituted 2-dialkylamino alkylbiphenyl derivatives
11/13/2002	CN1379675A 24-hydroxyvitamin D, analogs and use thereof
11/13/2002	CN1379671A Treating sleep disorders using desloratadine
11/13/2002	CN1379669A Valdecoxib compositions
11/13/2002	CN1379664A Activation and protection of cytotoxic lymphocytes using reactive oxygen metabolite inhibitor
11/13/2002	CN1379047A Match of organic medicine and beta-cyclodextrin derivative and its preparing process
11/12/2002	US6479673 Antiretroviral enantiomeric nucleotide analogs
11/12/2002	US6479663 Intermediates useful for the preparation of antihistaminic piperidine derivatives
11/12/2002	US6479655 TNF receptor promoter
11/12/2002	US6479635 Receptor activator of NF-κB
11/12/2002	US6479633 Chemokine alpha 2
11/12/2002	US6479540 Compositions of tocol-soluble therapeutics
11/12/2002	US6479527 Bicyclic pyrrole derivatives as MCP-1 inhibitors
11/12/2002	US6479516 4-arylpiperidine derivatives for the treatment of pruritus
11/12/2002	US6479507 Modulation of these inflammatory cytokines is considered one of the most effective strategies to block chronic inflammation and have positive therapeutic outcomes
11/12/2002	US6479505 6-arylphenanthridines with PDE-IV inhibiting activity
11/12/2002	US6479504 Antagonism of immunostimulatory CpG-oligonucleotides by 4-aminoquinolines and other weak bases
11/12/2002	US6479494 Arylalkanoyl pyridazines
11/12/2002	US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002	US6479490 Treatment of diseases characterized by excess th2 cytokines and/ or an excess ige production.
11/12/2002	US6479474 Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
11/12/2002	US6479284 Humanized antibody and uses thereof
11/12/2002	US6479270 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
11/12/2002	US6479247 Antibody for use in the treatment of cancer and arthritis
11/12/2002	US6478379 Chair
11/12/2002	CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/12/2002	CA2169635C Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
11/12/2002	CA2103242C Imidazo[2,1-b][3]benzazepine derivatives, compositions and method of use
11/12/2002	CA2009533C Novel cyclosporin galenic forms
11/11/2002	CA2385692A1 Thiazole derivatives
11/07/2002	WO2002088664A2 Control of compactability through crystallization
11/07/2002	WO2002088356A1 Novel g protein-coupled receptor protein and dna thereof
11/07/2002	WO2002088349A1 Method of examining allergic disease using cathepsin-c alternative splicing form as indication
11/07/2002	WO2002088336A2 Genetically modified yt cell line and use thereof
11/07/2002	WO2002088317A2 Fusion molecules and methods for treatment of immune diseases
11/07/2002	WO2002088316A2 G-protein coupled receptors
11/07/2002	WO2002088186A1 Anti-cd40 monoclonal antibody
11/07/2002	WO2002088172A2 Pentapeptide compounds and uses related thereto
11/07/2002	WO2002088167A1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
11/07/2002	WO2002088159A1 Pharmaceutically active uridine esters
11/07/2002	WO2002088156A1 Lipid a 1-carboxylic acid derivative
11/07/2002	WO2002088138A1 Novel 4-amino-5,6-substituted thiopheno[2,3-d]pyrimidines
11/07/2002	WO2002088137A1 Pkb-3564 substance with neovascularization inhibitory activity
11/07/2002	WO2002088123A1 Chemical compounds
11/07/2002	WO2002088122A1 Heterocyclic compounds
11/07/2002	WO2002088121A1 Pyrazolo[1,5-a]pyridines and medicines containing the same
11/07/2002	WO2002088111A1 Novel benzylpiperidine compound
11/07/2002	WO2002088107A1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
11/07/2002	WO2002088097A1 Triazole-derived kinase inhibitors and uses thereof

1 ... 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 ... 1172